ProPhase Labs, Inc.
PRPH
$0.02
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.01M | 478.00K | 784.00K | 883.00K | 1.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.01M | 478.00K | 784.00K | 883.00K | 1.25M |
| Cost of Revenue | 785.00K | 311.00K | 537.00K | 1.01M | 513.00K |
| Gross Profit | 226.00K | 167.00K | 247.00K | -123.00K | 734.00K |
| SG&A Expenses | 2.87M | 2.77M | 5.97M | 4.64M | 4.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.66M | 3.08M | 6.51M | 5.65M | 5.14M |
| Operating Income | -2.65M | -2.61M | -5.73M | -4.76M | -3.89M |
| Income Before Tax | -3.04M | -3.98M | -8.02M | -7.00M | -3.69M |
| Income Tax Expenses | 12.00K | 1.37M | -622.00K | -157.00K | 779.00K |
| Earnings from Continuing Operations | -3.05M | -5.35M | -7.40M | -6.84M | -4.47M |
| Earnings from Discontinued Operations | -- | -- | 0.00 | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.05M | -5.35M | -7.40M | -6.84M | -4.47M |
| EBIT | -2.65M | -2.61M | -5.73M | -4.76M | -3.89M |
| EBITDA | -1.68M | -1.64M | -4.76M | -3.73M | -2.55M |
| EPS Basic | -0.22 | -0.43 | -0.33 | -1.65 | -1.08 |
| Normalized Basic EPS | -0.15 | -0.19 | -0.26 | -1.09 | -0.39 |
| EPS Diluted | -0.22 | -0.43 | -0.33 | -1.65 | -1.08 |
| Normalized Diluted EPS | -0.15 | -0.19 | -0.26 | -1.09 | -0.39 |
| Average Basic Shares Outstanding | 14.02M | 12.32M | 22.12M | 4.15M | 4.15M |
| Average Diluted Shares Outstanding | 14.02M | 12.32M | 22.12M | 4.15M | 4.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |